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Abstract 
In 2014, The Society for Vascular Surgery revealed a new classification system for Critical Limb Ischemia (CLI) 
referred as the Society for Vascular Surgery Lower Extremity Threatened Limb Classification System based on 
Wound, Ischemia, and foot Infection (SVS WIfI). This scoring system was created to stratify major amputations 
risk within 1 year and benefit of revascularization for the patient. This study aimed to assess the accuracy of 
SVS WIFi in predicting major amputations in patients with lower limb ischemia underwent revascularization 
at Department of Surgery, Faculty of Medicine, Universitas Padjadjaran-Dr. Hasan Sadikin General Hospital in 
2016–2019. This was a retrospective observational analytic study with cohort design. Patients who fulfilled 
the inclusion criteria were assessed with SVS WIfI and results after 1 year of revascularization were identified. 
Data were analyzed statistically using the Chi-square test. 0f 56 subjects, 39 had limb salvage and 17 underwent 
major amputations within 1 year. In high revascularization benefit group, 31 had limb salvage and 7 underwent 
amputation. Meanwhile, in moderate-low revascularization benefits group, 8 had limb salvage and 10 underwent 
amputation. The accuracy of the SVS WIfI recommendation was 73.2%. Therefore, WIfI SVS classification 
accurately predicts the incidence of major amputations in patients with lower limb ischemia who underwent 
revascularization.
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Akurasi Klasifikasi SVS-WIfI dalam Memprediksi Amputasi Mayor pada 
Pasien Iskemik Tungkai Bawah
Abstrak 
Pada tahun 2014, The Society for Vascular Surgery mengemukakan sistem klasifikasi baru untuk Critical Limb 
Ischemia (CLI), yaitu SVS-WIfI. Sistem penilaian ini dibuat untuk mengelompokkan risiko amputasi mayor dalam 
waktu 1 tahun dan manfaat revaskularisasi bagi pasien. Penelitian ini bertujuan untuk menilai akurasi SVS WIFi 
dalam memprediksi amputasi mayor pada pasien iskemia ekstremitas bawah yang menjalani revaskularisasi di 
Departemen Ilmu Bedah Fakultas Kedokteran Universitas Padjadjaran/Dr. Rumah Sakit Umum Hasan Sadikin 
tahun 2016–2019. Penelitian ini merupakan penelitian observasional analitik dengan rancangan retrospective 
cohort study. Pasien yang memenuhi kriteria inklusi dinilai dengan SVS WIfI dan hasil setelah 1 tahun 
revaskularisasi diidentifikasi. Data dianalisis secara statistik menggunakan uji Chi-square. Berdasar atas penelitian 
yang dilakukan terhadap 56 pasien yang menjalani revaskularisasi, didapatkan sebanyak 39 pasien yang tidak 
mengalami amputasi mayor dan 17 pasien yang mengalami amputasi mayor dalam 1 tahun. Dari penelitian ini 
kelompok pasien dengan manfaat revaskularisasi yang tinggi didapatkan 31 pasien tidak mengalami amputasi, 
sedangkan 7 pasien mengalami amputasi, pada kelompok pasien dengan manfaat revaskularisasi sedang-rendah, 
8 pasien tidak mengalami amputasi, sedangkan 10 pasien mengalami amputasi. Akurasi dari rekomendasi SVS 
WIfI adalah 73,2%. Oleh karena itu, klasifikasi WIfI SVS secara akurat memprediksi kejadian amputasi mayor 
pada pasien dengan iskemia ekstremitas bawah yang menjalani revaskularisasi.
Kata kunci: Amputasi, revaskularisasi, SVS WIFi
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Introduction
Peripheral arterial disease (PAD) is the third 
cause of morbidity caused by atherosclerosis 
after coronary heart disease and stroke.1,2 The 
number of people with PAD arises because of the 
increase in life expectancy. The number of PAD 
cases has increased by 25% globally from 2000 
to 2010, and the mortality rate also increased 
by 2 to 3 times. People with PAD are widely 
distributed, mostly in South East Asia, with 
Indonesia having a PAD prevalence of 9.7%. 3,4
Peripheral arterial disease is stenosis, 
occlusion, and aneurysm of the aorta and its 
branches, other than the coronary arteries. The 
most common PAD at lower extremities takes 
the form of stenosis and occlusion.5 Peripheral 
arterial disease causes decreasing blood flow to 
the distal of the limb, which will lead to symptoms 
of ischemia such as intermittent claudication. 
Furthermore, if the arteries are blocked, it will 
cause Critical Limb Ischemia (CLI). The term 
CLI was first published in 1982 and, as science 
developed, it is subsequently defined as a 
clinical condition that describes limb pain when 
resting and injury or gangrene in the extremity 
caused by a prolonged arterial insufficiency 
process. Critical limb ischemia itself is a terminal 
condition of PAD.6
Patients with CLI have a higher amputation 
rate, approximately 25% in one year. Patients 
diagnosed with CLI are often associated with 
loss of limbs and revascularization.6 Several 
studies show that 50% of wounds on CLI can 
heal without revascularization. The challenge 
for these cases rests in making decisions to 
determine whether a patient can heal with 
normal wound treatment or should undergo 
revascularization. Revascularization itself must 
be decided carefully based on clinical conditions 
and the benefits after revascularization.6,7
In 2014, The Society for Vascular Surgery 
revealed a new classification system for CLI, the 
Society for Vascular Surgery Lower Extremity 
Threatened Limb Classification System based on 
Wound, Ischemia, and foot Infection (SVS WIfI).6 
The SVS WIfI scoring system was created to 
stratify the risk of major amputations within a 
year and benefit from patients’ revascularization. 
This classification assessment is based on the 
injury to the extremities, the presence of arterial 
insufficiency, and the presence of leg infection.
The challenges to determine proper 
management for CLI and the issuance of the new 
classification, which is still not widely used, have 
encouraged the authors to conduct this study.
Methods
This study was conducted at the Department 
of Surgery, Dr. Hasan Sadikin General Hospital, 
Universitas Padjadjaran,  in 2016–2019. The 
subjects were patients with CLI who underwent 
revascularization at Dr. Hasan Sadikin General 
Hospital and data on these subjects were 
retrieved from their medical records. The 
inclusion criteria for the subject were CLI 
patients underwent revascularization with 
complete medical records. Patients whose data 
were incomplete or those who died less than 
one year after revascularization were excluded. 
Data were then grouped according to the SVS 
WIfI classification and revascularization results 
were assessed to see whether the patient had an 
amputation within one year after the procedur. 
Statistical analysis was then conducted. 
The sample size calculation was carried out 
using a formula to determine the categorical 
analysis sample size. A sample size 2.0 program 
from Holmer and Lemeshow was used. A 
sample of 26 subjects per group was required 
and written consent was obtained from these 
subjects before the study. Data were collected 
electronically, stored in Microsoft Excel, and 
analyzed with SPSS version 24.0 for windows. 
The analysis was planned by the intent-to-
treat principle using the parametric and 
nonparametric tests. Continuous variables were 
analyzed with the Shapiro-Wilk test to test data 
normality. The P-value for categorical data was 
calculated based on the Chi-Square test with 
Kolmogorov Smirnov test and Exact Fisher as 
the alternatives when the requirements of Chi-
Square were not met. Statistical significance was 
defined as a p-value of 0.05 and 95% CI and 90% 
power test were applied. This research received 
ethical approval from the Medical Ethics 
Committee of Dr. Hasan Sadikin General Hospital 
(LB.02.01/X.6.5/301/2019). 
Results
There were 87 CLI patients who underwent 
revascularization during the study period. Of 
these, only 56 cases met the inclusion criteria. 
Sixteen cases had incomplete data, 8 cases 
died less than one year after revascularization, 
and 7 subjects could not be contacted after the 
revascularization treatment.
The mean age of subjects was 52.60±14.033 
years old. There were 39 male patients 
(69.6%) and 17 female patients (30.4%) and 
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Angioplasty Ballooning 2 (3.6%)
Aortofemoral Bypass 8 (14.3%)
Femorofemoral Bypass 7 (12.5%)
Femoroperoneus Bypass 1 (1.8%)
Femoropopliteal Bypass 6 (10.7%)
Femorotibial Bypass 30 (53.6%)
Ileofemoral Bypass 1 (1.8%)
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Patients who had major amputations after 
revascularization were 17 people (30.4%). 
Information on the characteristics of the subjects 
is listed in Table 1.
Study subjects were further classified into 
groups based on the WIfI classification as 
presented in Table 2. For the wound category, 
most patients who underwent revascularization 
most were in grade 3 (n=21, 37.5%). When 
observed from the ischemic status, most subjects 
were grade 2 (n=29, 51.8%) and 21 patietns 
(37.5%) experienced grade 1 foot infection. 
Subsequently, each sample was grouped based 
on the risk of amputation and the benefits of 
revascularization as described in the SVS WIfI. 
The majority of subjects were in the high-risk 
category for amputation (n=44, 78.6%) while 
the remaining 12 subjects (21/4$) were in the 
moderate-low risk.
In terms of revascularization benefits, the 
category of high benefits was seen in 38 patients 
(67.9%), and moderate-low benefits were seen 
in 18 patients (32.1%).
Table 3 explains the results of the statistical 
calculations between the wound, ischemic, foot 
infection, and major amputations. Statistical 
test results demonstrated that the P-value for 
the wound, ischemic, and foot infection was 
less than 0.05 (P-value <0.05), thus statistically 
significant. Therefore, it can be explained that 
statistically, the wound, ischemic, and foot 
infection variables have significant relationships 
major amputations.
Table 4 explains the comparison between 
the benefits of revascularization and the major 
amputation group. In the group without major 
amputations, 31 patients (79.5%) were in 
the high category for the revascularization 
benefits while the remaining eight (20.5%) 
were in the moderate-low category. In the group 
with major amputations, the high category of 
revascularization benefits was seen in seven 
patients (41.2%), and the moderate-low was 
observed in ten patients (58.8%). Statistical 
test results from the Chi-Square gave a p-value 
of less than 0.05 (P-value <0.05), which means 
significant or statistically significant. Therefore, 
there was a statistically significant relationship 
between the benefits of vascularity variables in 
the group without major amputations and with 
major amputations.
From the results of Table 4, the accuracy value 
of the WIfI SVS recommendation was 73.2%, 
meaning that it has a moderate accuracy value 
statistically.
20 (35.7%) patients suffered from diabetes 
mellitus. Sixteen patients suffered from heart 
disease (28.6%), while 26 (46.4%) patients 
and 10 (17.9%) suffered from hypertension 
and hypercholesterolemia, respectively. Of all 
patients, 41 patients (73.2%) were smokers. 
The most frequent revascularization was 
the femorotibial open bypass (n-30, 53.6%). 
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Table 2 Subject Characteristics by SVS WIFi Classification
Variable (n=56)
Wound
(No ulcer, ischemic rest pain) 8 (14.3%)
(Small, shallow ulcer on distal leg or foot without gangrene) 8 (14.3%)
(Deeper ulcer with exposed bone, joint or tendon, gangrene on toes) 19 (33.9%)
(Extensive deeper ulcer, full thickness heel ulcer, extensive gangren) 21 (37.5%)
Ischemic
(ABI ≥ 0.80) 0 (0%)
(ABI 0.60–0.79) 11 (19.6%)
(ABI 0.40–0.59) 29 (51.8%)
(ABI < 40) 16 (28.6%)
Foot infection
(No symptoms/signs of infection) 11 (19.6%)
(Local infection involving only skin and subcutaneous 21 (37.5%)
tissue)
(Local  infection  involving  deeper  than  skin  and 14 (25.0%)
subcutaneous tissue)
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Discussion
Patients with CLI will have to undergo limb 
amputation if not treated properly. This study 
shows the results of revascularization as an 
intervention to prevent major amputations in 
one year according to the recommendation of 
SVS WIfI. 11
Findings in this study demonstrated 
that 56 CLI patients who have undergone 
revascularization at Dr. Hasan Sadikin General 
Hospital Bandung are 52.6 years old on average 
with most of them are men. This finding is 
consistent with the literature stating that PAD 
rarely occurs in patients under the age of 40 
and that the risk of PAD occurrence will increase 
depending on age. Previous studies also declare 
that the PAD presents more signs and symptoms 
in men.4,12 This study also discovered that most 
patients with CLI were smokers and smoking has 
been mentioned as one of the risk factors that 
can cause atherosclerosis in peripheral arteries, 
which is the cause of PAD.
The most frequent revascularization 
procedure experienced by the subjects in this 
study isthe Femorotibial bypass. This statement 
is in line with the literature, stating that PADs 
occur at the femoral artery and popliteal.4,13
As depicted in this study, the higher the 
wound and foot infection levels are, the higher 
the amputation rate. Revascularization can 
only be performed when the foot infection is 
already under control.6 If the infection cannot be 
controlled, we should perform amputation for 
saving the life of the patient.
In this study, the variables used in the 
WIFi classification (Wound, Ischemic, and 
Foot Infection) have statistically significant 
relationships with major amputation, which is 
in line with the findings of Joseph et al. from the 
Society for Vascular Surgery.6,14
This study also discovered a statistically 
significant relationship between the benefits of 
revascularization and major amputations (Table 
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(No ulcer, ischemic rest pain) 5 (12.8%) 3 (17.6%)
(Small, shallow ulcer on distal leg or foot without gangrene) 6 (15.4%) 2 (11.8%)
(Deeper  ulcer  with  exposed  bone, oint or tendon, gangrene 
on toes) 19 (48.7%) 0 (0.0%)
     (Extensive deeper ulcer, full thickness heel ulcer, extensive    
     gangren) 9 (23.1%) 12 (70.6%)
Ischemic 0,025*
(ABI ≥ 0.80) 0 (0%) 0 (0%)
(ABI 0.60 – 0.79) 4 (10.3%) 7 (41.2%)
(ABI 0.40 – 0. 59) 22 (56.4%) 7 (41.2%)
(ABI < 40) 13 (33.3%) 3 (17.6%)
Foot Infection 0,000*
(No symptoms/signs of infection) 10 (25.6%) 1 (5.9%)
(Local infection involving only skin and subcutaneous tissue) 19 (48.7%) 2 (11.8%)
      (Local infection involving deeper than skin and subcutaneous 
      tissue)
7 (17.9%) 7 (41.2%)
(Systemic inflamatory response syndrome) 3 (7.7%) 7 (41.2%)
Note: P-value is calculated based on the Chi-Square test with alternative Kolmogorov Smirnov test and Exact Fisher if 
the requirements of Chi-Square are not met. The significance value is based on a p-value of <0.05. The sign * indicates a 
p-value of <0.05, meaning that it is significant or statistically significant.
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High 31 (79.5%) 7 (41.2%)
Moderate-low 8 (20.5%) 10 (58.8%)
Note: P-value is calculated based on the Chi-Square. The significance value is based on a p-value of <0.05. The sign * 
indicates a p-value of <0.05, meaning that it is significant or statistically significant.
4) with a P-value of 0.005, and this complies with 
the WIfI classification.6,8,15
From this study, it is observed that the 
vascular status is not the only consideration 
in the CLI treatment. There are also wound 
and foot infection that affect the result of 
revascularization. The SVS WIfI recommendation 
can be used as a guide for deciding whether a 
patient should undergo revascularisation or 
amputation. If the revascularization benefits are 
low, it will be better to perform the amputation 
to lower mortality and morbidity.
This study has a limitation in that the 
classification into groups based on WifI was 
only done by a researcher, which may lead to 
bias. This study can be further developed with a 
better research design, such as the prospective 
cohort design, and by involving more experts to 
assess the initial wound condition to reduce bias.
Thus, WIfI SVS classification accurately predicts 
the incidence of major amputations in critical 
limb ischemic patients that have undergone 
revascularization, making it suitable to be used 
as a guideline to treat these patients. 
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